Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.48 |
| ▸ | RXRA | P19793 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3361585 | 0.95 | CES2 (0.47) | ALDH1A1GAAKDM4EABCG2RXRA | |
| SCHEMBL985849 | 0.87 | CES2 (0.41) | ALDH1A1GAAKDM4EABCG2CES2 | |
| SCHEMBL19024606 | 0.87 | CA1 (0.50) | KDM4ERXRACES2CES1LMNA | |
| SCHEMBL24653922 | 0.87 | BACE1 (0.46) | ALDH1A1KDM4EABCG2CES2CES1 | |
| SCHEMBL986399 | 0.87 | HPGD (0.44) | GAAKDM4EABCG2CES2CES1 | |
| SCHEMBL4276392 | 0.87 | P4HB (0.43) | ALDH1A1GAAKDM4EABCG2RXRA | |
| SCHEMBL3612973 | 0.86 | NPC1 (0.45) | ALDH1A1GAAKDM4EABCG2CES2 | |
| SCHEMBL31026223 | 0.86 | NPC1 (0.45) | ALDH1A1GAAKDM4EABCG2CES2 | |
| SCHEMBL988436 | 0.86 | KMT2A (0.43) | ALDH1A1GAAKDM4EABCG2RXRA | |
| SCHEMBL5226850 | 0.86 | CA1 (0.52) | ALDH1A1GAAKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 652 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116813454-B | Synthetic method of pterostilbene | 珠海市柏瑞医药科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-116813454-A | Synthetic method of pterostilbene | 珠海市柏瑞医药科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-112358487-B | Lappaconitine derivative, and preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2023-08-25 | — | — | CN | claimed |
| WO-2022099937-A1 | LAPPACONITINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 中国科学院新疆理化技术研究所 | 2022-05-19 | — | — | WO | claimed |
| US-20210386906-A1 | METHODS AND FORMULATIONS FOR TRANSDERMAL ADMINISTRATION OF DERMAL CONTOURING AGENTS | DYVE BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | US | claimed |
| CN-112358487-A | Lappaconitine derivative and preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2021-02-12 | — | — | CN | claimed |
| CN-107840792-A | A kind of synthetic method of resveratrol | 常州大学 | 2018-03-27 | — | — | CN | claimed |
| WO-2005122670-A2 | BIOMONITORED SYNTHESIS ROUTE FOR LARGE SCALE PREPARATION OF CARDOL (BILOBOL) AND 11Δ-CARDOL | KARDOL INDÚSTRIA QUÍMICA LTDA. (BR) | 2005-12-29 | — | — | WO | claimed |
| EP-1228056-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. LUNDBECK A/S (DK) | 2002-08-07 | — | — | EP | claimed |
| US-6407267-B1 | USING GRIGNARD REAGENT; ANTIDEPRESSANT | H. LUNDBECK A/S (DK) | 2002-06-18 | — | — | US | claimed |
| US-20020035277-A1 | Method for the preparation of citalopram | H. LUNDBECK A/S (DK) | 2002-03-21 | — | — | US | claimed |
| CN-1331685-A | Process for the preparation of citalopram | LUNDBECK & CO AS H (DK) | 2002-01-16 | — | — | CN | claimed |
| WO-2000012044-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. LUNDBECK A/S (DK) | 2000-03-09 | — | — | WO | claimed |
| CN-122036735-A | Pyrazolo [3,4-d ] pyrimidine-hydroxamic acid derivatives, synthetic method and application | 云南大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-121949077-A | Preparation method of resveratrol and application of resveratrol in meat preservation | 浙江天启生化股份有限公司 | 2026-05-01 | — | — | CN | disclosed |
| US-12577243-B2 | Monoacylglycerol lipase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-17 | — | — | US | disclosed |
| US-4064254-A | ANTIARRHYTHMIC AND ANTISEROTONINE AGENTS | MEAD JOHNSON & COMPANY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4001426-A | HAVING CORONARY VASODILATOR ACTIVITY | SMITHKLINE CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-4000143-A | ANTIARRHYTHMIC AND ANTISEROTONIN AGENTS | MEAD JOHNSON & COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3931195-A | ANTIARRHYTHMIA, ANTISEROTONIN | MEAD JOHNSON & COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035277-A1 | Method for the preparation of citalopram | HTR6, HTR1A, HTR1F | ALDH1A1 929/4885GAA 2889/4885KDM4E 865/4885 |
| US-12577243-B2 | Monoacylglycerol lipase modulators | MGLL, LPL, FAAH | ALDH1A1 587/4885GAA 290/4885KDM4E 3565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.